Las Vegas, NV -- (SBWIRE) -- 01/10/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Boyd Gaming Corporation(NYSE:BYD), Affymetrix, Inc.(NASDAQ:AFFX), Exelixis, Inc.(NASDAQ:EXEL), Blackstone Mortgage Trust Inc(NYSE:BXMT)
Boyd Gaming Corporation(NYSE:BYD) was a volume gainer of 4.29 million shares and the average volume of the stock remained 2.38 million shares. The stock opened the session at $11.94 and finished at the end of the day at $11.85 and the stock plunged -0.59%.The market capitalization of the stock remained 1.28 billion. Boyd Gaming Corporation, together with its subsidiaries, operates as a multi-jurisdictional gaming company in the United States. The company operates in five segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, Peninsula Gaming, and Atlantic City.
Has BYD Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Affymetrix, Inc.(NASDAQ:AFFX) exchanged 4.28 million shares and the average volume remained 917,573.00 shares. The stock closed the session at $9.41 with the gain of 5.02%. Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia. The company operates in two segments, Affymetrix Core and eBioscience.
Will AFFX Continue To Move Higher? Find Out Here
Exelixis, Inc.(NASDAQ:EXEL) enhanced 2.71% and its closing price was $7.19. The volume of the stock was 3.96 million shares and the average volume remained 1.74 million shares. The market capitalization of the stock remained 1.32 billion. The beta of the stock remained 1.99. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib), an inhibitor of multiple receptor tyrosine kinases for the treatment of progressive, metastatic medullary thyroid cancer.
Why Should Investors Buy EXEL After The Recent Gain? Just Go Here and Find Out
Blackstone Mortgage Trust Inc(NYSE:BXMT) exchanged 3.96 million shares in the previous trading session, and its average trading remained 336,286.00 shares. BXMT dropped -0.55% and it closed the trading at $27.30. The market capitalization of the stock remained 799.13 million. Blackstone Mortgage Trust, Inc., a real estate finance company, primarily focuses on originating mortgage loans backed by commercial real estate assets. It intends to originate, acquire, and manage commercial real estate loans, and securities and other commercial real estate-related debt instruments.
Has BXMT Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)